ROPIVACAINA KABI 5mg / ml injectible solution medication leaflet

N01BB09 ropivacaine • Nervous system | Anesthetics, local | Amides

Ropivacaine is an amide-type local anesthetic used for regional anesthesia and the management of acute or chronic pain. It works by blocking sodium channels in neuronal membranes, inhibiting nerve impulse transmission and inducing numbness in the treated area.

Ropivacaine is administered via injection, typically during surgical procedures, childbirth, or for postoperative pain management. It is preferred due to its long duration of action and a more favorable safety profile compared to other local anesthetics, with a lower risk of systemic toxicity.

Common side effects include hypotension, nausea, dizziness, and injection site reactions. In rare cases, severe adverse reactions such as systemic toxicity or allergic responses may occur. Administration should be performed by a qualified professional with careful patient monitoring.

Ropivacaine is a safe and effective option for local anesthesia and pain management, enhancing patient comfort in various medical settings.

General data about ROPIVACAINA KABI 5mg / ml

Substance: ropivacaine

Date of last drug list: 01-07-2013

Commercial code: W55682004

Concentration: 5mg / ml

Pharmaceutical form: injectible solution

Quantity: 1

Product type: generic

Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Concentrations available for ropivacaine

10mg/h, 10mg/ml, 2mg/ml, 5mg/ml, 7.5mg/ml